PhRMA director of public affairs on 340B exploitation: ‘Evidence shows that 340B entities markup medicines by as much 1,000% or more’

State Issues Texas takes action against three pharmacies for violating state regulations Jul 1, 2025

State Issues USP reports persistent drug shortages with an average duration exceeding four years Jul 1, 2025

State Issues North Carolina confirms first measles case in 2025 Jul 1, 2025

PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients' Jun 30, 2025

Regulatory Iowa board files charges against FarmaKeio, citing FDA and California actions Jun 30, 2025

State Issues Michigan launches MiBusiness Registry Portal for improved business filing services Jun 30, 2025

People

CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

• Leonard named new president of the Association for Accessible Medicines
• Best in health care showcased in 2020 We Work for Health Champion Awards
• Grein: Those suffering from COVID-19 receiving experimental treatments
• APRECIA: Kimberly Bone, PharmD, named Aprecia's Vice President of Medical & Clinical Affairs

Innovation

Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

• Vaccination efforts for frontline health care workers underway following Pfizer vaccine approval
• PTCB: Pharmacy Technician Certification Board (PTCB) Rolls Out Advanced Certification for Experienced Pharmacy Technicians Who Have Comprehensive Knowledge and Skills
• AZD1222 vaccine meets base requirements in efficacy for preventing, treating COVID-19
• endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows

Regulatory

Iowa board files charges against FarmaKeio, citing FDA and California actions Jun 30, 2025

• Pediatrician: 'Large corporations are using the 340B program as a cash cow'
• Former FTC director on 340B program: ‘Drug discounts are being captured by corporate hospital systems'
• Researcher on 340B: Physicians 'select patients who require more intensive pharmaceutical treatments after joining the 340B program'
• National Consumers League announces poll showing support for 340B drug pricing reform

Industry

Trader on Eli Lilly lawsuit: 'There is decades of legal precedent allowing the compounding of medications under the 503A exemption' Jun 27, 2025

• Empower Pharmacy founder: 'The most expensive part of your medication isn’t the drug. It’s the middleman'
• Empower Pharmacy CEO on pharmaceutical lobbying pressure: 'A resurgence of compounding is coming'
• Empower Pharmacy challenges Eli Lilly tirzepatide patent before U.S. Patent Trial and Appeal Board
• Monty's Home Medical highlights benefits of tailored compounded medications

Federal Issues

Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

• FDA issues emergency authorization for Pfizer COVID-19 vaccine
• FDA allows state-sponsored drug importation
• AZD1222 vaccine meets base requirements in efficacy for preventing, treating COVID-19
• FDA, border patrol and ICE coordinate to target mailed contraband

State Issues

Georgia pharmacy technicians enter active-renewal pending status Jul 1, 2025

• PSM warns about counterfeit Ozempic injections with specific serial numbers
• FDA warns of risks linked to compounded topical finasteride products
• FIP updates guide to expand pharmacists' role in vaccination services
• Potential medication mix-ups between Inflectra and Zymfentra prompt safety warnings